(ZH) JPMorgan Warns Of $170 Billion In Forced Month-End Selling

JPMorgan Warns Of $170 Billion In Forced Month-End Selling

Last week, when previewing Friday's massive, $1.8 trillion quad witching Op-Ex, which culminated a material swing lower in stocks if without any major fireworks, we also observed that according to Goldman, as of last Tuesday's close, there was a net $76bn of equities to sell as pension funds rebalance for quarter end; this would be the third largest estimate on record, only behind Mar 2020 and Dec 2018, both of which happened to be extremely volatile periods.
In retrospect, Goldman may have been conservative because when adding all the other possible sources of month- and quarter-end forced rebalancing, the total amount "for sale" soars to an unprecedented $170 billion according to calculations by JPMorgan.
In the latest Flows and Liquidity report from JPM's Nikolas Panagirtzoglou, writes that after correctly pointing out at the market lows on March 23 that there is a massive $1.1 trillion in rebalancing flow into equities, all of that has since been balanced out and three months later, we are looking at a substantial outflow of about $170BN before month end, resulting in a "small correction."
To reach his ominous conclusion, Panagirtzoglou looks at the five main entities that have either fixed allocation targets or tend to exhibit strong mean reversion in their asset allocation. These are:

  • balanced mutual funds such as 60:40 funds,
  • US defined benefit pension plans,
  • Norges Bank, i.e. the Norwegian sovereign wealth fund,
  • the hedge fund formerly known as the SNB
  • and the Japanese government pension plan GPIF
Here are some more details on each of these rebalancing vehicles:
  • Balanced mutual funds including 60:40 funds, a $6.9tr AUM universe globally at the end of 2019 but closer to $5tr at the equity market low on March 23rd, had according to JPMorgan around $460bn of pending equity buying as of March 23rd. Given the tendency of these funds to rebalance relatively quickly on a monthly basis, 2/3rds of that rebalancing flow was done by the end of March and by the end of April these funds were close to be fully rebalanced. For both the end of April and the end of May JPM estimated modest negative rebalancing flows of -$25bn and -$60bn respectively. By taking into account the MTD performance of global equities and bonds, the bank estimates that around -$70bn of negative equity rebalancing flow by balanced mutual funds globally into the current month end.
  • US defined benefit pension plans, with $7.5tr AUM at the end of last year but below $6tr at the equity market low on March 23rd, had, on around $500bn of pending equity buying as of March 23rd. Given the tendency of these pension funds to rebalance more slowly over 1-2 quarters or so, a quarter of that rebalancing flow was done by the end of March and then largely concluded by the end of May. Fast forwarding to June 30, the bank estimates that the pending equity rebalancing flow by US defined benefit pension funds into the current quarter end is likely modestly negative at around -$65bn, or roughly in line with Goldman's estimate noted above.
  • Norges Bank, with $1.2tr AUM at the end of last year but closer to $900bn at the equity market low on March 23rd, had, on our estimates, around $63bn of pending equity buying as of March 23rd. Like with Pension funds, JPM calculates that most of the rebalancing has been concluded, and concludes that the pending equity rebalancing flow by Norges Bank into the current quarter end is likely modestly negative at around -$10bn.
  • The SNB also invests a considerable proportion of its foreign currency assets, accumulated over the course of its FX interventions since 2008, in equities, which are laid out in the central bank's hedge fund's quarterly 13F reports. For bonds, JPM looks at the SNB’s quarterly fixed income allocations as well as the currency allocation, and approximate the returns of its bond portfolio by using our GBI country indices for 1-10Y maturity buckets in order to better match the SNB’s reported average duration, which was around 4.6 years in its most recent report. Based on the SNB’s reported allocation, the JPM strategist estimates that the SNB bought around $30bn of equities in 1Q20 and sold around $8bn of bonds. Essentially, it appears that much of foreign currency accumulated as it began to intervene more aggressively in March was invested in equities. As a result, for 2Q, the bank assumes that the allocation is unchanged from 1Q, and given the level of reserves up to end-May as well as equity and bond returns over the same period this suggests the SNB may need to sell around $15bn of equities given the recovery from March lows, and buy around $33bn of bonds.
  • The Japanese government pension plan GPIF, with $1.5tr AUM at the end of last year but closer to $1.2tr at the equity market low on March 23rd, had around $73bn of pending equity buying as of March 23rd, of which about a quarter was completed by March 30. Additionally, JPM believes that the pending rebalancing flow by GPIF had declined to around $30bn by the end of March and to $10bn by the end of April. Assuming half of that rebalancing flow was done by the end of April or so, and by taking into account the global equity and bond performance since then, Panigirtzoglou estiamtes that the pending equity rebalancing flow by GPIF into the current quarter end is likely negative at around - $25bn.
Looking at the continued surge in stocks which however has failed to mirror a similar move in bonds, JPM concludes that "not only has the continuation of the equity market rally into June naturally eroded all of the previously estimated positive equity rebalancing flow, but it has likely created a need for negative rebalancing flow, i.e. equity selling, of around $170bn into the current month/quarter end." Still, before the bank's clients who read other JPM strategist - such as Mislav Matejka who just upgraded the US to a buy overnight, freak out and ask why there are so many conflicting messages coming from the same bank, Panigirtzoglou caveats that "this $170bn should be thought of as an upper estimate as it is possible that same of this equity selling was done before quarter end."
And while the JPM quant acknowledges the risk of a small correction in equity markets over the coming two weeks as a result of this negative equity rebalancing flow, he "continues to believe that we are in a strong bull market in equities and any dip would represent a buying opportunity."

Because, well... you know.

>>> US Gapping down


Gapping down

Other news:

  • AAL -8.3% (proposed offerings of $750,000,000 of shares of its common stock and $750,000,000 of its convertible senior notes due 2025)
  • MIST -5.1% (files for $100 mln mixed securities shelf offering)
  • ICL -2.4% (will consolidate sales and marketing infrastructures for crop nutrition inputs to drive internal synergies and optimize distribution channels)
  • WRTC -2.3% (files for 3 mln share common stock offering by selling shareholders)
  • PD -1.9% (commences private placement of $250 million principal amount of Convertible Senior Notes due 2025)
  • PTCT -0.8% (files for 760,365 share common stock offering)
  • CNNE -0.8% (announces investment in Trebia Acquisition)

Analyst comments:

  • DOMO -3.6% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
  • MUR -3.4% (downgraded to Neutral from Buy at Goldman)
  • NCLH -3% (downgraded to Neutral from Buy at Redburn)
  • PLAB -2.7% (downgraded to Hold from Buy at Stifel)
  • CPA -2.4% (downgraded to Outperform from Strong Buy at Raymond James)
  • NVMI -2.2% (downgraded to Hold from Buy at Stifel)
  • ALB -1.8% (downgraded to Underweight from Sector Weight at KeyBanc Capital Markets)
  • CCL -1.6% (downgraded to Neutral from Buy at Redburn)
  • RCL -1.6% (downgraded to Neutral from Buy at Redburn)
  • MRO -1.4% (downgraded to Sell from Neutral at Goldman)
  • BIIB -1.3% (downgraded to Equal Weight from Overweight at Barclays)
  • ACLS -1.2% (downgraded to Hold from Buy at Stifel)
  • FL -1% (downgraded to Neutral from Buy at B. Riley FBR)
  • IFF -0.9% (downgraded to Underperform from Neutral at Exane BNP Paribas)
  • KHC -0.7% (downgraded to Sell from Neutral at Goldman)
  • LRCX -0.7% (downgraded to Hold from Buy at Stifel)
  • KLAC -0.6% (downgraded to Hold from Buy at Stifel)

>>> US Gapping up


Gapping up
In reaction to strong earnings/guidance
:

  • SHW +0.9%, DBD +0.5%

Other news:

  • THTX +39.6% (announces data featuring its investigational sortilin 1 (SORT1)-targeting peptide-drug conjugate technology at AACXR)
  • HOOK +16% (announces 'positive' results on its prophylactic Cytomegalovirus (CMV) vaccine candidate HB-101)
  • SPCE +13.7% (signs space act agreement with NASA for private orbital spaceflight to the international space station)
  • ALT +8.1% (FDA has cleared its IND application to conduct a Phase 2 trial of HepTcell for the treatment of chronic hepatitis B)
  • CIDM +7.7% (partners with Team Whistle; announces multi-film deal with Glass House Distribution )
  • NIO +7.4% (Tencent (TCEHY) confirmed increased active stake fo 15.1%)
  • AGEN +4.4% (enters agreement with Betta Pharma for an exclusive collaboration and license agreement for the development and commercialization of balstilimab and zalifrelimab in Greater China)
  • XCUR +4% (presents updated pharmacodynamic and safety data at the AACR Virtual Annual Meeting)
  • PCG +3.7% (Achieves bankruptcy court confirmation of its plan of reorganization; expects to emerge from Chapter 11 in July)
  • PAYS +3.6% (files for 1,514,166 share common stock offering by selling shareholders)
  • SUPV +3.1% (announces that Founder Patricio Supervielle will resume role as CEO)
  • PUMP +2.2% (completes review process and files formerly delinquent 2019 annual and quarterly reports - did not identify any items that would require revision or restatement)
  • HCKT +1.5% (to pay dividends on a quarterly basis; declares quarterly dividend of $0.095/share)
  • AGTC +1.5% (provided an update on the continued productivity and quality improvements made in its proprietary manufacturing platform that is currently being used to create clinical trial material for the Company's planned pivotal clinical trials in X-linked retinitis pigmentosa)
  • AUPH +1.3% (confirmed the FDA approved the New Drug Application for GIMOTI )
  • TAK +1% (provides update of the financial impact of the European Commission's decision to release TAK from commitment to divest Shire's (SHPG) pipeline compound SHP647)

Analyst comments:

  • GPS +6.1% (upgraded to Overweight from Underweight at Wells Fargo)
  • TS +2.2% (upgraded to Buy from Sell at Goldman)
  • CAG +1.6% (upgraded to Buy from Hold at Jefferies)
  • DKNG +1.5% (initiated with a Buy at Jefferies)
  • ALGT +1.2% (upgraded to Strong Buy from Outperform at Raymond James)
  • WMT +1% (upgraded to Buy at UBS)
  • HLT +0.9% (upgraded to Overweight from Equal Weight at Barclays)
  • JCI +0.9% (upgraded to Buy from Neutral at UBS)
  • CPB +0.8% (upgraded to Buy from Hold at Jefferies)

>>> US Early premarket gappers


Early premarket gappers

  • Gapping up:
    • AUPH +106%, SPCE +21.2%, CIDM +15.5%, NIO +5.7%, SUPV +3.1%, PCG +2.2%, PUMP +2.2%, HCKT +1.5%, ARR +1.1%, TAK +1%, PAYS +0.5%
  • Gapping down:
    • AAL -8.3%, ICL -2.4%, PTCT -0.8%, CNNE -0.8%, FDX -0.7%, WRTC -0.5%

>>> Europe : Brokers Upgradezs & Downgrades - 22nd of June 2020 V2(+)

>>> Up
* Adecco Raised to Reduce at AlphaValue
* Bunzl Raised to Neutral at Credit Suisse; PT 2,175 pence (+)
* Carrefour Raised to Overweight at JPMorgan; PT 17 euros
* Experian Raised to Outperform at Credit Suisse; PT 3,450 pence (+)
* Fevertree Drinks Raised to Outperform at RBC; PT 2,500 pence
* G4S Raised to Outperform at Credit Suisse; PT 140 pence (+)
* Grafton Raised to Add at Peel Hunt
* Hilton Worldwide Raised to Overweight at Barclays; PT $90
* Hunting Raised to Buy at Goldman; PT 340 pence
* Marriott Intl Raised to Overweight at Barclays; PT $105
* Partners Group Raised to Buy at Goldman; PT 1,000 Swiss francs
* Randstad Raised to Neutral at Credit Suisse; PT 38 euros (+)
* Rentokil Raised to Outperform at Credit Suisse; PT 650 pence (+)
* SGS Raised to Neutral at Credit Suisse; PT 2,200 Swiss francs (+)
* Siemens Gamesa Raised to Overweight at JPMorgan; PT 18 euros
* Tenaris Raised to Buy at Goldman; PT 7.60 euros
* Tenaris ADRs Raised to Buy at Goldman; PT $17
* Travis Perkins Raised to Buy at Peel Hunt

>>> Down
* Ashmore Cut to Sell at Berenberg; PT 331 pence
* Bodycote Cut to Sell at Goldman; PT 520 pence
* Europris Cut to Hold at Nordea (+)
* Kraft Heinz Cut to Sell at Goldman; PT $30
* M1 Kliniken Cut to Hold at Commerzbank; PT 12 euros (+)
* Maersk Cut to Hold at NYKREDIT; PT 8,800 kroner
* Man Group Cut to Hold at Berenberg; PT cut from 160 to 148 pence
* Metall Zug Cut to Hold at MainFirst; PT 2,300 Swiss francs
* Siemens Cut to Hold at LBBW; PT 96 euros
* Vestas Cut to Hold at NYKREDIT; PT 700 kroner

>>> Initiation
* HAEMATO AG Rated New Hold at Commerzbank; PT 2.60 euros (+)
* Nikola Rated New Neutral at JPMorgan; PT $45
* X5 Retail GDRs Rated New Overweight at Morgan Stanley; PT $40

>>> Call
* Ashmore Cut on Tough Outlook, Man Group Downgraded: Berenberg
* Codemasters Results Show Key Risks Have Been Diffused: Jefferies (+)
* Fevertree’s U.S. Opportunity is Intact, RBC Raises to Outperform
* Partners Group Raised at Goldman, Bullish on Product Demand (+)
* Royal Mail Estimates Cut on Costs Offsetting Parcel Volume: Citi
* Siemens Gamesa ‘Turning the Tide,’ Gets Double-Upgrade From JPM (+)
* Tenaris, Hunting Double Upgraded By Goldman on Shale Outlook (+)
* Workspace’s Growing Flexible Leases Offset by Weak U.K. GDP: RBC (+)

>>> TradeGate Pre-MArket Indications

DAX:
  • Deutsche Telekom +0.4%
  • Vonovia -0.1%
  • HeidelbergCement -0.2%
  • Henkel -0.7%
  • RWE -0.8%
  • Bayerische Motoren Werke -0.9%
  • BASF -1.0%
  • Deutsche Boerse -1.1%
  • Linde -1.1%
  • Merck -1.1%
  • Fresenius -1.8%
  • EON -1.9%
  • Bayer -1.9%
  • Adidas -1.9%
  • Continental -2.2%
  • SAP -2.3%
  • Deutsche Bank -2.4%
  • MTU Aero Engines -4.6%
  • Deutsche Lufthansa -7.9%
    • Lufthansa CEO Says Bailout May Not Pass on Lack of Support
  • Wirecard -40.7%
    • Wirecard Says Missing $2.1 Billion Probably Doesn’t Exist
MDAX:
  • Fraport +0.8%
  • Symrise +0.7%
  • Deutsche Wohnen +0.5%
  • Nemetschek +0.3%
  • METRO +0.1%
  • TAG Immobilien +0.1%
  • Duerr -0.2%
  • Cancom -0.3%
  • Evonik Industries -0.3%
  • Siemens Healthineers -0.4%
  • Puma -2.6%
  • Telefonica Deutschland -2.3%
  • Aareal Bank -2.2%
  • Commerzbank -2.0%
  • ProSiebenSat.1 -2.0%
  • HochTief -1.8%
  • Airbus -1.7%
  • Fuchs Petrolub -1.6%
  • Hella -1.6%
  • Freenet -1.4%
SDAX
  • Hamburger Hafen +0.9%
  • Hornbach +0.9%
  • Stroeer +0.7%
  • SMA Solar +0.6%
  • W&W +0.6%
  • Varta +0.3%
  • Hamborner REIT +0.3%
  • Takkt +0.2%
  • HelloFresh 0.0%
  • SGL Carbon -3.9%
  • Wacker Chemie -3.7%
  • SAF-Holland -3.1%
  • Amadeus Fire -3.1%
  • Traton -2.4%
  • Nordex -2.3%
  • Deutsche EuroShop -2.3%
  • Bilfinger -2.3%
  • ADO Properties -1.8%
  • Encavis -1.8%